{
    "a3abbe7b-6f9b-3e40-9cbb-1eee957b67c4": {
        "uuid": "a3abbe7b-6f9b-3e40-9cbb-1eee957b67c4",
        "title": "Portugal's Positive Approach to Teaching Teens about the Birds, Bees and STIs",
        "publisher": "News Direct",
        "link": "https://finance.yahoo.com/news/portugals-positive-approach-teaching-teens-124608104.html",
        "providerPublishTime": 1653655568,
        "type": "STORY"
    },
    "c7a190f2-a003-3889-971c-cc17293af397": {
        "uuid": "c7a190f2-a003-3889-971c-cc17293af397",
        "title": "Analyst Report: Gilead Sciences, Inc.",
        "publisher": "Morningstar Research",
        "link": "https://finance.yahoo.com/m/c7a190f2-a003-3889-971c-cc17293af397/analyst-report%3A-gilead.html",
        "providerPublishTime": 1653603335,
        "type": "STORY"
    },
    "71d9dd8c-8557-3055-a844-891a59adcb36": {
        "uuid": "71d9dd8c-8557-3055-a844-891a59adcb36",
        "title": "Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?",
        "publisher": "Benzinga",
        "link": "https://finance.yahoo.com/news/why-nrx-pharmaceuticals-shares-trading-114606785.html",
        "providerPublishTime": 1653565566,
        "type": "STORY"
    },
    "bb8009d0-7e4e-3a75-bb73-24829d2cb8a5": {
        "uuid": "bb8009d0-7e4e-3a75-bb73-24829d2cb8a5",
        "title": "Peninsula biotech breaks off hepatitis B deal after partner's drug falters",
        "publisher": "American City Business Journals",
        "link": "https://finance.yahoo.com/m/bb8009d0-7e4e-3a75-bb73-24829d2cb8a5/peninsula-biotech-breaks-off.html",
        "providerPublishTime": 1653491162,
        "type": "STORY"
    },
    "a9fe34f6-8dce-31f3-ae61-a54a545fb61f": {
        "uuid": "a9fe34f6-8dce-31f3-ae61-a54a545fb61f",
        "title": "Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report",
        "publisher": "News Direct",
        "link": "https://finance.yahoo.com/news/gilead-reaches-number-one-spot-132606662.html",
        "providerPublishTime": 1653485166,
        "type": "STORY"
    },
    "871b1096-f3eb-3a88-a0fb-534e06c76980": {
        "uuid": "871b1096-f3eb-3a88-a0fb-534e06c76980",
        "title": "The Zacks Analyst Blog Highlights JPMorgan Chase, Gilead Sciences, CSX, CVS Health and China Petroleum & Chemical",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-jpmorgan-102210060.html",
        "providerPublishTime": 1653301330,
        "type": "STORY"
    },
    "19835d26-01ca-3da4-b6fd-eecbf488dc05": {
        "uuid": "19835d26-01ca-3da4-b6fd-eecbf488dc05",
        "title": "Top Research Reports for JPMorgan, Gilead Sciences & CSX",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/top-research-reports-jpmorgan-gilead-170805049.html",
        "providerPublishTime": 1653066485,
        "type": "STORY"
    },
    "d25e0d60-f2cd-3bab-a4fa-e35d8d8a1e1d": {
        "uuid": "d25e0d60-f2cd-3bab-a4fa-e35d8d8a1e1d",
        "title": "Gilead at Forefront of Herculean Effort to Combat COVID-19",
        "publisher": "News Direct",
        "link": "https://finance.yahoo.com/news/gilead-forefront-herculean-effort-combat-140107010.html",
        "providerPublishTime": 1653055267,
        "type": "STORY"
    }
}